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ABSTRACT 
 
Dietary regimens involving fasting have long been linked to beneficial health outcomes 
including; reduction in heart disease, diabetes, improved mood and cognition, and resistance to sickness 
behaviors such as anorexia and fever.  The mechanisms underlying fasting-induced health benefits and 
alterations in immunity and sickness behavior continues to remain debated despite over 20 years of 
interest.  This research project confirms that acute dietary restriction (24 h water-only fast) is able to 
attenuate IL-1β-induced anorexia, in addition to other sickness behaviors at early stages of the acute 
phase response. We previously reported that fasting was able to reduce gene expression of 
inflammatory IL-1α in the brain, here we looked at liver and adipose in addition to brain and uncovered 
a major up-regulation of IL-1 endogenous inhibitors, IL-1RA and IL-1R2 in peripheral tissues. These 
findings imply that attenuation in sickness behaviors observed may be due to counter-regulation of IL-1 
via up-regulation of IL-1R2 and/or IL-1RA shown in metabolically active organs, which is capable of 
blunting the centrally-mediated effects of induced peripheral challenge. Our results further demonstrate 
that the mechanisms involved in IL-1R2 and IL-1RA up-regulation are independent of IL-1, TLR-4, IL-4 and 
glucocordicoid signaling. Here we also demonstrate that free fatty acids (FFA) are increased in the 
plasma as a consequence of fasting. Using palmitic acid injection to mimic fastings FFA increase, we 
elucidated a novel mechanism by which IL-1R2 is up-regulated. This method showed increased IL-1R2 
gene transcripts in the liver of mice. FFA signaling, which produces an immune response, is shown here 
to be TLR-4-independent, implicating free fatty acid receptor 1 (FFAR1) as the key signaling receptor 
initiating the anti-inflammatory result of fasting documented in this study. 
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW 
 
Within the last 20 years, the importance of body weight has become a physiological metric that 
has permeated the cultural psyche of nearly all industrialized nations. Weight loss has become a near 
societal obsession (Fraser, 1997). Many popular diet programs initially use significant calorie restriction 
(CR) to facilitate relatively rapid weight-loss (Volpe, 2006) including the recent trend of detox and/or 
cleansing diets which may incorporate water only fasting for up to 1 wk. In a broad context, however, 
fasting is a critical element of many religious and cultural practices (Brett & Nesbit, 2012; Salim, Al 
Suwaidi, Ghadban, Alkilani, & Salam, 2013) and is recommended by practitioners of alternative and 
complementary medicine as therapy for a variety of ailments (Fuhrman, Sarter, & Calabro, 2002; 
Goldhamer et al., 2002; Michalsen, 2010; Schmidt et al., 2010). Clinically, dietary regimens that 
incorporate intermittent fasting (IF) have gained significant popular attention (The Fast Diet: Lose 
Weight, Stay Healthy, and Live Longer with the Simple Secret of Intermittent Fasting, Dr. Michael 
Mosley) with human studies showing a potential to reduce heart disease and diabetes (Horne et al., 
2008) and to improve mood (Michalsen et al., 2006; Michalsen, 2010). Since fasting regimens appear to 
benefit cognition function in aging mice (Martin, Mattson, & Maudsley, 2006) and in the 3xTgAD mouse 
model of Alzheimer’s disease, (Halagappa et al., 2007) interest in CR and IF as a way to ward off human 
cognitive aging has also emerged (Mattson, 2010).  
 
While overeating and obesity are associated with a variety of maladies including type 2 diabetes 
(T2D), heart disease, stroke (Kopelman, 2007), cancer (Louie, Roberts, & Nomura, 2013) Alzheimer’s 
disease (Lee, 2011), anxiety/mood disorders (Kaczmarczyk et al., 2013; Simon et al., 2006), and declined 
cognition (Bressler et al., 2013), precisely how overnutrition contributes is not entirely clear. Emerging 
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evidence indicates that oxidative and metabolic stress in conjunction with dyslipedemia and excess 
glucose stimulates the unfolded protein response (Scheuner & Kaufman, 2008) and activates the NLRP3 
inflammasome (Vandanmagsar et al., 2011). Thus, IL-1-mediated inflammation is a key consequence of 
overnutrition, whether indirectly provoked by cellular injury (Gregor & Hotamisligil, 2011) or directly 
triggered by excess nutrients acting as danger signals (Lumeng, 2013). Overnutrition-associated IL-1 is 
implicated in pancreatic beta cell loss in T2D, atherogenesis in heart disease and stroke and 
neurodegeneration in Alzheimer’s disease (Cai & Liu, 2012) but, in general, IL-1 is a critical effecter of 
sickness symptoms that include loss of appetite, locomotion and social/environmental engagement 
(Kelley et al., 2003). Thus, ameliorations that inhibit IL-1 bioaction may positively impact health in those 
with either psychological (Maes, Song, & Yirmiya, 2012; Rossi et al., 2012) and/or overtly organic 
diseases (Dayer, 2003; Sloan-Lancaster et al., 2013). 
 
We recently demonstrated that mice fasted for 24 hrs have reduced gene expression of brain IL-
1α (Lavin et al., 2011), indicating that CR may be a physiologic way to negatively regulate IL-1 bioaction. 
Although starvation appears detrimental to immunity, as evidenced by lipopolysaccharide (LPS)-induced 
death in bees and mice (Faggioni, Moser, Feingold, & Grunfeld, 2000; Moret & Schmid-Hempel, 2000), 
fasting appears to mitigate LPS-induced sickness symptoms in rats (Inoue, Somay, Poole, & Luheshi, 
2008). In addition, fasting offers protection from ischemic (Mitchell et al., 2010) and hypoxic injuries 
(Go, Prenen, & Korf, 1988) which we and others have shown are mediated in large part by IL-1 (Chiu et 
al., 2012; Johnson, O'Connor, Hartman, Tapping, & Freund, 2007). Therefore, we examined if the 
beneficial effects of fasting are due to IL-1 counter-regulation in both the systemic and neuroimmune 
systems. 
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CHAPTER 2 
OBJECTIVES 
 
 
1. Determine how fasting alters the immune system and if there are any cognitive or behavioral effects 
associated with fasting. 
 
2. Determine what happens to a previously fasted immune system after being challenged with IL-1β, and 
elucidate whether these changes are associated with alterations in sickness behaviors with this immune 
stimuli. 
 
3. Determine the mechanism by which fasting alters the immune system. 
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CHAPTER 3 
METHODOLOGY 
 
 Materials- All reagents and chemicals were purchased from Sigma-Aldrich (St Louis, MO) except 
as noted. All primers were purchased from Applied Biosystems (Foster City, CA) 
 
 Animals- Procedures were conducted on protocols approved by the University of Illinois 
Institutional Animal Care and Use Committee. IL-1 receptor 1 (IL-1R1) knock out (KO), toll-like receptor 
(TLR-4) KO, IL-4 KO and C57BL/6J (wild type (WT)) mice were purchased from Jackson Laboratory (Bar 
Harbor, ME) and bred in-house. All KO mice were on a C57BL/6 backbone. Mice were group housed (×8 
cage) in standard shoebox cages (length 46.9 cm; width 25.4 cm; height 12.5 cm) and allowed water and 
food (Harlan XXX (Indianapolis, IN) ad libitum except where otherwise noted. Housing temperature (72 
°F) and humidity (45–55%) were controlled as was a 12/12 h reversed dark-light cycle (light = 2200-1000 
h). Animals were sacrificed using CO2 except for those in which corticosterone was measured which 
were sacrificed using ketamine/xylazine.   
 
Fasting and mouse weight- As previously described (Lavin et al., 2011; York et al., 2012), 2 days 
prior to fasting, mice were singly housed. Fasting was initiated by placing mice in a new cage without 
food but with ad libitum water. Mice were fasted for 24 h starting at 0900 h. Mouse weight was 
recorded immediately before and immediately after fasting using an Ohaus Adventurer Pro digital scale 
(Parsippany, NJ).  
 
Injectables- Millipore recombinant mouse IL-1β (Billercia, MA) in 100 μl of sterile Cellgro PBS 
(Manassas, VA) (vehicle) was administered intraperitoneally (IP) at a dose of 0.9 μg/mouse immediately 
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after fasting. Mifepristone in BioUltra 400 polyethylene glycol (PEG) (vehicle) (PEG) was administered 
subcutaneously (SC) at a dose of 25 mg/kg immediately prior to fasting. Palmitic acid in 50 μL of castor 
oil (vehicle) was administered IP at a dose of 30 μMoles. 
 
Quantitative PCR (qPCR)- As previously described (Lavin et al., 2011), animals were perfused 
with 30 mLs of ice cold PBS and RNA isolated from homogenized tissues using Qiagen RNeasy Lipid 
Tissue Mini Kits (Valencia, CA). RNA was reverse transcribed using the Applied Biosystems High-Capacity 
cDNA Reverse Transcription Kit. The TaqMan Gene Expression primers used were: CD11b 
(Mm00434455_m1), TNF-α (Mm00443258_m1), IL-1α (Mm99999060_m1), IL-1β (Mm99999061_mH), 
IL-1R1 (Mm00434237_m1), IL-1RA (Mm01337566_m1) and IL-1R2 (Mm00439622_m1). qPCR was 
performed on an Applied Biosystems 7900 HT Fast Real-Time PCR System using Applied Biosystems 
TaqMan Universal PCR Master Mix. To compare gene expression, a parallel amplification of endogenous 
RPS3 (Mm00656272_m1) was performed. Reactions with no reverse transcription and no template were 
included as negative controls. Relative quantitative evaluation of target gene to RPS3 was performed by 
comparing ΔCts, where Ct is the threshold concentration.  
 
Locomotion- Spontaneous locomotor activity was measured as previously described (Lavin et al., 
2011, York et al., 2012). At the times indicated, mice were video recorded in their home cage for 5 min 
under red light using a using a Sony Night Shot capable video camera (Minato-ku, Tokyo). Distance 
moved was quantified using Noldus Information Technology EthoVision XT 7 automated tracking 
software (Leesburg, VA).  
  
Social Behavior- Social exploration of a novel juvenile was measured as previously described 
(Sherry, Kramer, York, & Freund, 2009). In brief, a 4-wk old novel, conspecific male juvenile (challenge) 
 6 
 
mouse enclosed in a 3 x 3 x 3 inch wire mesh cage was placed in the home cage of the adult (test) mouse 
for 5 minutes. Test mouse-initiated exploratory behavior of the challenge mouse enclosure was video 
recorded under red light using a using a Sony Night Shot capable video camera. Time spent exploring the 
challenge mouse (nose within a 2 cm region of interest (ROI) drawn around the caged juvenile) was 
quantified using Noldus Information Technology EthoVision XT 7 automated tracking software 
(Leesburg, VA). 
 
Blood glucose- Mouse tail blood glucose was determined in duplicate using an Abbott 
Laboratories AlphaTRAK Blood Glucose Monitoring System (North Chicago, IL) by methods we have 
previously described (Lavin et al., 2011).  
 
Serum and liver IL-1R2 and IL-1RA- Serum IL-1R2 was measured using a Millipore Milliplex MAP 
kit (Billerica, MA) following manufactures instructions. Bead-based fluorescent reporter signal was 
detected on a Luminex 100 System (Austin, TX). Serum IL-1RA was measured colorimetrically in by ELISA 
using the R&D Mouse IL-1RA/IL-1F3 conjugate kit (Minneapolis, MN). Liver IL-1R2 and IL-1RA were 
measured from freeze-fractured liver by methods we have previously described (Chiu et al., 2012). In 
brief, PBS perfused livers were liquid nitrogen frozen in freeze fracture buffer containing 10% glycerol, 
50 mM NaCl, 1 mM EDTA, 50 mM HEPES (pH 7.4) plus a 1:200 dilution of Millipore protease inhibitor 
cocktail (Billerica, MA). The fractured liver was homogenized using the TissueLyser II (Qiagen, Valencia, 
CA) at a rotational frequency of 30/sec for 2 min. Lysates were clarified at 16,000 x g for 15 min at 4º C 
and the supernatant protein concentrations determined using the Bio-Rad DC Protein Assay (Hercules, 
CA). Liver IL-1R2 and IL-1RA was expressed as pg of IL-1R2 per ng of supernatant protein. 
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 Plasma corticosterone and free fatty acids (FFAs)- Corticosterone was measured colorimetrically 
by ELISA using the Abcam corticosterone ELISA kit (Cambridge, MA) in  plasma. FFAs were measured 
colorimetrically in plasma using the Randox Nefa Assay (Antrim, Ireland) and a Beckman-Coulter AU680 
(Brea, CA) following manufactures instructions. 
 
Statistics- Individual behavioral experiments were performed on separate cohorts of mice. 
Biochemical/qPCR experiments were performed on cohorts of mice not subjected to behavioral testing. 
All data are presented as mean ± SEM. Data were analyzed using Sigma Plot 11.2 (Systat 
Software,Chicago, IL). To test for statistical differences, one-way and two-way ANOVAs were used with 
or without repeated measurements where relevant. Tukey’s test was used for post-hoc pair-wise 
multiple comparison procedures. Pearson product moment correlation was used to compute correlation 
coefficient. Where indicated, raw data was transformed to attain normality or equal variance via 
log(abs), ^2  or RANK simple transforms. All statistical analysis included testing for time point x 
treatment interactions. Statistical significance was denoted at p<0.05. 
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CHAPTER 4 
RESULTS 
1. Effect of fasting on gene expression 
Table 1 shows that CD11b, TNF-α, IL-1α, IL-1β, IL-1R1, IL-1RA and IL-1R2 gene transcripts after fasting 
are differentially expressed in brain regions (hypothalamus, hippocampus, cortex), and peripheral 
tissues (liver, adipose).  In all brain regions, fasting caused CD11b gene transcript to significantly 
downregulate ( p<0.001 all brain regions). Whereas both adipose and liver upregulated CD11b (p<0.001 
adipose, p=0.032 liver; transformed to RANK for normality).  TNF-α was consistently downregulated in 
all tissues (p=0.001 hypoth, p=0.002 hippo, p<0.001 cortex, p=.004 adipose, 0=.045 liver). IL-1α was 
significantly downregulated in all brain regions (p<0.001 all brain regions), but adipose and liver 
transcript was not significantly different due to fasting. IL-1β gene message was significantly 
downregulated in the hypothalamus (p<0.006 hypoth) and also in adipose tissue (p=.008 adipose), but 
was not significantly different in any other tissues. IL-1R1 was significantly upregulated in all tissues 
measured (p=0.008 hypoth,p= 0.031 hippo, p<0.001 cortex, p<0.001 adipose, p=0.017 liver). IL-1RA 
message was significantly upregulated in hippocampus (p=0.046 hippo) as well as in the liver (p<0.001 
liver), but was downregulated in the adipose (p=0.014), and remained unchanged in hypothalamus and 
cortex. IL-1R2 was not significantly different in any brain regions, but was significantly upregulated in 
both adipose and liver (p=0.008 adipose, p=0,016 liver), both transformed to RANK for equal variances. 
 2. IL-1R2 and IL-1RA protein increase in liver after 24 h fast.   
Table 2 shows that, in agreement with up-regulated gene transcript of IL-1R2, mice subjected to a 24 h 
fast had increased IL-1R2 protein in the liver, p=0.004; data transformed to log(abs) for normality. Also 
in agreement with up-regulated gene transcript of IL-1RA, mice subjected to a 24 h fast had increased IL-
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1RA protein in the liver, p<0.001; data transformed to log(abs) for equal variance. No significant 
difference in serum IL-1R2 or IL-1RA protein due to fasting. 
3. Fasting effects social exploratory behavior in mice 
Fig. 1A shows that a 24 h fast causes significant increased social interaction in mice (Fed 165.2± 13.9 vs. 
Fasted 210.5± 6.22). Main effect significant at p=0.015. Fig. 1B shows that fasting has no significant 
effect on locomotor behavior in mice (Fed 3155.0± 267.4 vs. Fasted 2916.3± 190.6). No significance at 
p=0.484. There was no significance seen with additional adverse behavior tests or cognitive deficits 
observed when tested with these other paradigms: Open Field, Novel Object Recognition, or Y-Maze 
(data not shown). 
4. Fasting induces resistance to IL-1β-induced sickness behavior. 
Fig. 2A shows that fasted mice are resistant to decreased social exploratory behavior of a juvenile 2 h 
after IL-1β injection (Fed Saline 123.048  16.493s vs. Fasted Saline 172.414  9.737s vs. Fed IL-1β 
62.721  13.082s vs. Fasted IL-1β 112.900  22.296s); main effects of treatment (P<0.001) and state 
(P=0.004), no treatment-state interaction (P=0.980). Fig. 2B demonstrates that fasting a mouse prior to 
injecting with inflammatory IL-1β induces resistance to sickness as shown by resistance to decreased 
locomotor activity at 2 h, spontaneous locomotor activity was measured 2 h post injection (Fed Saline 
1213.374  36.764cm vs. Fasted Saline 1012.946  115.244cm vs. Fed IL-1β 131.176  74.121cm vs. 
Fasted IL-1β 731.617  110.055cm); main effects of treatment (P<0.001) and state (P=0.046), 
treatment-state interaction (P<0.001). Fig. 2C Shows that mice subjected to a 24 h fast were resistant to 
IL-1β-induced sickness weight loss.  Mice were weighed 2 h post injection and compared to their initial 
weight (0 h) prior to treatment (Fed Saline -0.400  0.204g vs. Fasted Saline  -0.300  0.108g vs. Fed IL-
1β -1.280  0.180g vs. Fasted IL-1β -0.240  0.067g); main effects of treatment (P=0.016) and state 
(P=0.002), treatment-state interaction (P<0.007). Fig. 2D Shows that fasting mice for 24 h prior to IL-1β 
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immune challenge induces resistance to IL-1β-induced decrease in blood glucose.  Blood glucose was 
measured 2 h post injection and compared to their initial blood glucose (0 h) prior to treatment (Fed 
Saline -12.000  18.898mg/dl vs. Fasted Saline -5.750  18.368mg/dl vs. Fed IL-1β -111.200  
14.900mg/dl vs. Fasted IL-1β -11.400  7.619mg/dl); main effects of treatment (P=0.004) and state 
(P=0.003), treatment-state interaction (P<0.007).  
5. Effect of challenging mice with IL-1β on brain region cytokine transcripts  
Fig. 3A demonstrates that challenging mice peripherally with IL-1β induces IL-1R2 gene transcript 
changes in specific brain regions regardless of a prior 24 h fast. 2 h post injection, brain regions were 
harvested (Hypothalamus-Hypoth, Hippocampus-Hippoc, Cortex-Cortex), gene transcripts were 
measured as relative fold ∆mRNA (Hypoth; Fed, Saline 1.000 +0.119  vs. Fasted, Saline 1.272 +0.036  vs. 
Fed, IL-1β  1.817 +0.189  vs. Fasted, IL-1β 1.877 +0.233); main effects of treatment (P<0.001) and state 
(P=0.182), no significant treatment-state interaction (P=0.300). (Hippoc; Fed, Saline 1.000 +0.172  vs. 
Fasted, Saline 1.150 +0.103  vs. Fed, IL-1β  1.811 +0.245  vs. Fasted, IL-1β 2.290 +0.312); main effects of 
treatment (P<0.001) and state (P=0.169), no significant treatment-state interaction (P=0.720). (Cortex; 
Fed, Saline 1.000 +0.030  vs. Fasted, Saline 1.274 +0.068  vs. Fed, IL-1β  1.579 +0.124  vs. Fasted, IL-1β 
1.900 +0.104); main effects of treatment (P<0.001) and state (P=0.002), no significant treatment-state 
interaction (P=0.614). Fig. 3B demonstrates that challenging mice peripherally with IL-1β induces IL-1RA 
gene transcript changes in specific brain regions regardless of a prior 24 h fast. 2 h post injection, brain 
regions were harvested (Hypothalamus-Hypoth, Hippocampus-Hippoc, Cortex-Cortex), gene transcripts 
were measured as relative fold ∆mRNA (Hypoth; Fed, Saline 1.000 +0.442  vs. Fasted, Saline 0.461 
+0.037  vs. Fed, IL-1β  52.130+2.897  vs. Fasted, IL-1β 34.184 +3.063); main effects of treatment 
(P<0.001) and state (P<0.001), no significant treatment-state interaction (P=0.747), data transformed to 
RANK for normality. (Hippoc; Fed, Saline 1.000, +0.412  vs. Fasted, Saline 0.870, +0.267  vs. Fed, IL-1β  
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49.634 +8.322  vs. Fasted, IL-1β 31.402 +5.176); main effects of treatment (P<0.001) and state (P=.245), 
no significant treatment-state interaction (P=0.525). (Cortex; Fed, Saline 1.000, +0.063  vs. Fasted, Saline 
1.118 +0.175  vs. Fed, IL-1β  23.641 +3.136  vs. Fasted, IL-1β 16.506 +2.57); main effects of treatment 
(P<0.001) and state (P=.339), no significant treatment-state interaction (P=0.082). Fig. 3C demonstrates 
that challenging mice peripherally with IL-1β induces IL-1α gene transcript changes in specific brain 
regions regardless of a prior 24 h fast. 2 h post injection, brain regions were harvested (Hypothalamus-
Hypoth, Hippocampus-Hippoc, Cortex-Cortex), gene transcripts were measured as relative fold ∆mRNA 
(Hypoth; Fed, Saline 1.000 +0.179  vs. Fasted, Saline 0.707 +0.036  vs. Fed, IL-1β  13.471 +0.613  vs. 
Fasted, IL-1β 10.354 +1.21); main effects of treatment (P<0.001) and state (P=0.013), no significant 
treatment-state interaction (P=0.700). (Hippoc; Fed, Saline 1.000, +0.065  vs. Fasted, Saline 0.739 +0.063  
vs. Fed, IL-1β  7.638 +0.557  vs. Fasted, IL-1β 7.665 +1.57); main effects of treatment (P<0.001) and state 
(P=.210), no significant treatment-state interaction (P=0.200). (Cortex; Fed, Saline 1.000, +0.074  vs. 
Fasted, Saline 0.546 +0.074  vs. Fed, IL-1β  8.907 +0.955  vs. Fasted, IL-1β 7.347 +1.362); main effects of 
treatment (P<0.001) and state (P=0.01), no significant treatment-state interaction (P=0.168). Fig. 3D 
demonstrates that challenging mice peripherally with IL-1β induces IL-1β gene transcript changes in 
specific brain regions regardless of a prior 24 h fast. 2 h post injection, brain regions were harvested 
(Hypothalamus-Hypoth, Hippocampus-Hippoc, Cortex-Cortex), gene transcripts were measured as 
relative fold ∆mRNA (Hypoth; Fed, Saline 1.000 +0.412  vs. Fasted, Saline 0.425 +0.067  vs. Fed, IL-1β  
72.810 +14.91  vs. Fasted, IL-1β 69.313 +9.665); main effects of treatment (P<0.001) and state (P=0.061), 
no significant treatment-state interaction (P=0.091). (Hippoc; Fed, Saline 1.000, +0.134  vs. Fasted, 
Saline 0.977, +0.044  vs. Fed, IL-1β  11.289 +1.355  vs. Fasted, IL-1β 12.606 +2.138); main effects of 
treatment (P<0.001) and state (P=.715), no significant treatment-state interaction (P=0.583). (Cortex; 
Fed, Saline 1.000, +0.053  vs. Fasted, Saline 0.849 +0.110  vs. Fed, IL-1β  11.119 +1.708  vs. Fasted, IL-1β 
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10.391 +1.480); main effects of treatment (P<0.001) and state (P=.347), no significant treatment-state 
interaction (P=0.693). 
6. Substantial up-regulation in liver and adipose IL-1R2 gene expression and in liver IL-1RA gene 
expression and their correlations to percent weight loss. 
Fig. 4A shows that IL-1R2 is substantially upregulated in the liver after a 24 h fast. There is a significant 
difference in average fold change in mRNA in liver fed vs. fasted (1.082± 0.095 vs. 27.975± 13.853) 
significant main effect, p<0.001 run on ∆CT values transformed to ^2 for normality. Fig. 4B shows that 
percent weight loss is negatively correlated to ∆CT value, data ran by Pearson Correlation test. The more 
weight the mouse lost during a 24 h fast, the lower the ∆CT value in PCR was for IL-1R2 gene expression 
in liver, and liver IL-1R2 correlation coefficient was -0.530, p=0.002..  Fig. 4C shows that IL-1R2 is 
substantially upregulated in adipose with a significant difference in average fold change in mRNA in 
adipose fed vs. fasted (1.118± 0.089 vs. 69.577± 21.829) significant main effect, p<0.001 run on ∆CT 
values transformed to RANK for normality. Fig. 4D shows that percent weight loss is negatively 
correlated to ∆CT value, data ran by Pearson Correlation test. The more weight the mouse lost during a 
24 h fast, the lower the ∆CT value in PCR was for IL-1R2 gene expression in adipose. Adipose IL-1R2 
correlation coefficient was -0.601, p<.001. Fig. 4E shows that IL-1RA is also substantically upregulated in 
the liver after a 24 h fast and there was a significant difference in average fold change in mRNA in liver 
fed vs. fasted (1.219± 0.140 vs. 33.792± 6.292) significant main effect, p<0.001. Fig. 4F shows that 
percent weight loss was not significantly correlated to ∆CT value for IL-1RA in liver, correlation 
coefficient  -0.306, p=0.094. There was no significant correlation in any groups to age of mouse at fast 
(between 9-14wks) and ∆CT value for IL-1R2 or IL-1RA, data not shown.  There was also no correlation 
between starting weight at time of fast and ∆CT value for IL-1R2 or IL-1RA, data not shown. 
7. IL-1R2 and IL-1RA gene expression on CD11b+, CD11b- and hepatocytes isolated from liver.   
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Fig. 5A shows that IL-1R2 is primarily expressed only in those cells with CD11b when compared to 
CD11b- cells. Although there was no significance between fed or fasted in either isolated cell group, 
CD11b+ cells had significantly more expression of IL-1R2 than CD11b- cells (CD11b+ Fed 1.000, +0.206-
0.171 vs. CD11b+ Fasted .902, +0.285-0.216 vs. CD11b- Fed 0.001, +0.000- 0.000 vs. CD11b- Fasted 
0.001, +0.000-0.000); main effects of cell type (P<0.001) and state (P=0.024), no significant cell type-
state interaction (P=0.444). Fig. 5B shows that IL-1RA is primarily expressed only in those cells with 
CD11b when compared to CD11b- cells. Although there was no significance between fed or fasted in 
either isolated cell group, CD11b+ cells had significantly more expression of IL-1RA than CD11b- cells 
(CD11b+ Fed 1.000, +0.221-0.181 vs. CD11b+ Fasted .620, +0.051-0.047 vs. CD11b- Fed 0.027, +0.002- 
0.002 vs. CD11b- Fasted 0.022, +0.004-0.003); main effects of cell type (P<0.001) and state (P=0.058), no 
significant cell type-state interaction (P=0.454). Fig. 5C shows that IL-1R2 expression is not different due 
to the fasting state in isolated hepatocytes (Fed 1.000, +0.337-0.252 vs Fasted 0.847 +0.223-0.176). Fig. 
5D shows that IL-1RA expression is upregulated after a 24 h fast in hepatocytes (Fed 1.000, +0.199-0.166 
vs. 7.146 +2.509-1.857) p=0.001. Fig5E shows that allowing a piece of liver to sit in buffer for 6 h after 
harvest, compared to extracting RNA within 1 h, significantly decreases IL-1R2 message (1.000, +0.219-
0.180 vs. 0.013, +0.001-0.001), p<0.001, and also significantly decreases IL-1RA message (1.000, +0.175-
0.149 vs. 0.437, +0.022-0.021), p=0.009. 
8. Effect of fasting on gene expression of IL-1R2 and IL-1RA in liver and adipose of knockout mouse 
models. 
Table 3 shows that IL-1R2 and IL-1RA gene transcripts after fasting in the liver and adipose are not 
impacted by knockout of IL-1R1, TLR-4 or IL-4 genes in mouse models.  In IL-1R1 KO mice, fasting 
significantly up-regulated IL-1R2 mRNA by 8 fold in the liver (p=0.021), and by 18 fold in the adipose 
(p=.007). Fasting of IL-1R1 KO mice also significantly up-regulated IL-1RA mRNA in the liver by 16 fold 
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(p<0.001), and had no significant difference in adipose IL-1RA. In TLR-4 KO mice, fasting significantly up-
regulated IL-1R2 mRNA by 7 fold in the liver (p<0.005), and by 9 fold in the adipose (p=.002), data 
transformed to RANK for equal variances. Fasting of TLR-4 KO mice also significantly up-regulated IL-1RA 
mRNA in the liver by 16 fold (p<0.001), and had no significant difference in adipose IL-1RA. In IL-4 KO 
mice, fasting significantly up-regulated IL-1R2 mRNA by 8 fold in the liver (p<0.050), and by 22 fold in the 
adipose (p=.022). Fasting of IL-4 KO mice also significantly up-regulated IL-1RA mRNA in the liver by 13 
fold (p<0.001), and had no significant difference in adipose IL-1RA. None of these groups were 
statistically different from their WT controls (data not shown). 
9. Effect of fasting on plasma corticosterone levels in mice. 
Fig. 6A confirms that a 24 h fast causes significant increased plasma corticosterone levels in mice (Fed 
368.120± 28.590 vs. Fasted 754.828± 84.421). Main effect significant at p=0.004. Fig. 6B shows that this 
increase in plasma corticosterone is significantly positively correlated (correlation coefficient 0.899) with 
percent body weight lost by the mouse in a 24 h fast, (p=0.005).  
10. Effect of inhibiting glucocorticoid receptor activity on IL-1R2 and IL-1RA gene transcripts in liver. 
Fig. 7A demonstrates that inhibiting glucocorticoid signaling via  GCR antagonist (Mifepristone) does not 
effect IL-1R2 gene transcripts in the liver after a 24 h fasting period. Mouse liver was harvested after a 
24 h fast and IL-1R2 gene transcripts were measured as relative fold ∆mRNA (Fed None 1.000, +0.103 -
0.094;  vs. Fasted None 4.247, +0.623 -0.543; vs. Fed Mifepristone 1.789, +0.299 -0.256; vs. Fasted 
Mifepristone 4.790, +0.609 -0.540; vs. Fed PEG 1.327, +0.126 -0.115; vs. Fasted PEG 3.471, +0.661 -
0.555); main effects of treatment (P=0.058) and state (P<0.001), no significant treatment-state 
interaction (P=0.160). Fig. 7B also demonstrates that inhibiting glucocorticoid signaling via GCR 
antagonist (Mifepristone) does not effect IL-1RA gene transcripts in the liver after a 24 h fasting period. 
Mouse liver was harvested after a 24 h fast and IL-1RA gene transcripts were measured as relative fold 
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∆mRNA (Fed None 1.000, +0.144 -0.126;  vs. Fasted None 8.939, +1.691 -1.422; vs. Fed Mifepristone 
1.236, +0.157 -0.140; vs. Fasted Mifepristone 9.521, +1.587 -1.260; vs. Fed PEG 1.086, +0.152 -0.133; vs. 
Fasted PEG 5.182, +1.395 -1.099); main effects of treatment (P=0.077) and state (P<0.001), no significant 
treatment-state interaction (P=0.161). 
11. Effect of fasting and palmitic acid injection on NEFA levels in mice. 
Fig. 8A shows fasting causes plasma NEFAs to double (Fed 0.927± 0.104 vs. Fasted 2.207± 0.161), and 
this was significant at p<0.001. Fig. 8B shows that palmitic acid injection mimics fasting plasma NEFAs 
increase  2 h after palmitic acid injection (Vehicle 0.881± 0.165 vs. Palmitic 1.63± 0.103); main effects of 
treatment (P=0.003).  
12. Liver IL-1R2 gene transcription levels after palmitic acid injection 
Fig. 9A shows that IL-1R2 is upregulated in the liver of mice 2 h after they are injected with palmitic acid. 
Palmitic injected mice had significantly more expression of IL-1R2 in liver than vehicle controls (Vehicle  
1.000, +0.213-0.175 vs. Palmitic 5.06, +3.07-1.91); significant main effect (P=0.01). Fig. 9B shows that IL-
1R2 is significantly increased in the liver 2 h after palmitic acid regardless of TLR-4. (WT, Vehicle 1.000, 
+0.113-0.101 vs. WT. Palmitic 3.267, +0.592-0.501 vs. TLR-4, Vehicle 0.97, +0.085- 0.078 vs. TLR-4, 
Palmitic 2.91, +0.558-0.468); main effects of treatment (P<0.001) no significant effect of genotype 
(P=0.645), no significant treatment-genotype interaction (P=0.75).  
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CHAPTER 5 
TABLES, FIGURES AND FIGURE LEGENDS
 
Table 1
Effect of fasting on gene expression
Tissue Hypothalamus Hippocampus Cortex Adipose Liver
Fed Fasted Fed Fasted Fed Fasted Fed Fasted Fed Fasted
CD11b 1.000 
(0.05,0.05)
0.577*
(0.03,0.03)
1.000 
(0.01,0.01)
0.599* 
(0.03,0.03)
1.000 
(0.04,0.04)
0.540* 
(0.04,0.03)
1.000 
(0.06,0.06)
3.732* 
(0.58,0.50)
1.000 
(0.10,0.09)
6.016* 
(2.69,1.64)
TNF-α 1.000 
(0.18,0.15)
0.479* 
(0.03,0.02)
1.000 
(0.09,0.08)
0.614* 
(0.06,0.05)
1.000 
(0.07,0.07)
0.607* 
(0.02,0.02)
1.000 
(0.28,0.22)
0.170* 
(0.03,0.02)
1.000 
(0.10,0.09)
0.660* 
(0.08,0.07)
IL-1α 1.000 
(0.06,0.06)
0.567* 
(0.03,0.03)
1.000 
(0.05,0.05)
0.565* 
(0.02,0.02)
1.000 
(0.10,0.09)
0.496* 
(0.02,0.02)
1.000 
(0.58,0.36)
0.295 
(0.04,0.04)
1.000 
(0.14,0.12)
0.857 
(0.03,0.03)
IL-1β 1.000 
(0.17,0.14)
0.487* 
(0.05,0.05)
1.000 
(0.08,0.07)
0.791 
(0.06,0.05)
1.000 
(0.12,0.11)
0.9018 
(0.10,0.09)
1.000 
(0.36,0.26)
0.167* 
(0.03,0.03)
1.000 
(0.12,0.11)
.979 
(0.33,0.25)
IL-1R1 1.000 
(0.10,0.09)
1.484* 
(0.12,0.11)
1.000 
(0.20,0.16)
1.600* 
(0.18,0.10)
1.000 
(0.03,0.03)
1.319* 
(0.05,0.05)
1.000 
(0.11,0.10)
2.334* 
(0.35,0.30)
1.000 
(0.12,0.11)
3.130* 
(0.95,0.69)
IL-1RA 1.000 
(0.32,0.24)
0.920 
(0.24,0.19)
1.000 
(0.11,0.09)
1.600* 
(0.33,0.27)
1.000 
(0.14,0.12)
1.066 
(0.11,0.10)
1.000 
(0.24,0.19)
0.254* 
(0.07,0.06)
1.000 
(1.55,0.64)
68.482* 
(38.6,24.7)
IL-1R2 1.000 
(0.12,0.11)
1.104 
(0.04,0.04)
1.000 
(0.09,0.09)
0.880 
(0.09,0.08)
1.000 
(0.04,0.04)
1.061 
(0.06,0.05)
1.000 
(0.25,0.02)
83.424* 
(79.0,40.5)
1.000 
(0.14,0.12)
9.467* 
(19.3,6.35)
Results are expressed as relative fold change in mRNA (∆mRNA), means (SEM upper, SEM lower); n=4-9
* p< 0.05, significant (One-way ANOVA)
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Table 2 
Effect of fasting on protein in liver (pg IL-1R2 or IL-1RA/ng total 
protein) and protein in serum (pg/mL) 
                   IL-1R2                 IL-1RA  
 Fed Fasted Fed Fasted 
Liver 8,475.2 
±1,837.4 
 
27,140.4* 
±8,993.1 
 
29,054.4 
±3,580.0 
 
71,722.6* 
±11,176.4 
 
Serum 11,112.2 
±392.7 
 
10,646.6 
±350.4 
661.9 
±112.7 
693.6 
±95.7 
Results are expressed as means (±SEM); Liver IL-1R2, n=7-8.  
Liver IL-1RA, n=13-16. Serum IL-1R2, n=8. Serum IL-1RA, n=8  
* p< 0.05, significant (One-way ANOVA) 
 
 
 
Table 2  IL-1R2 and IL-1RA protein increase in liver after 24 h fast. Mice were subjected to either a 24 h 
fast (Fasted), or continued to feed ad lib (Fed). IL-1R2 results are expressed as pg IL-1R2/ng total liver 
protein, means (  SEM); n=7-8. *p <0.05. IL-1RA results are expressed as pg IL-1RA/ng total liver 
protein, means (  SEM; n=13-16. *p<0.001. Serum IL-1R2 and IL-1RA levels are not significant, results 
are expressed as pg/mL.  
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Figure 1.  Fasting effects social exploratory behavior, but not locomotor activity in mice. Mice were 
subjected to either a 24 h fast (Fasted), or continued to feed ad lib (Fed).  (A) Mice were introduced to a 
novel juvenile mouse and allowed to explore for 5 minutes. Results are expressed as seconds (s) spent 
being socially interactive, means (±SEM); n=8. Significant main effect (*p <0.05). (B) Locomotor activity 
was tracked for a 5 minute interval. Results are expressed as centimeters (cm) moved, means (±SEM); 
n=6.  
0
50
100
150
200
250
Fed Fasted
S
o
c
ia
l 
I
n
te
ra
c
ti
o
n
 (
s
)
*
0
500
1000
1500
2000
2500
3000
3500
4000
Fed Fasted
L
o
c
o
m
o
to
r 
A
c
ti
v
it
y
 (
c
m
)
A 
B 
 19 
 
 
 
 
 
 
Figure 2  Fasting induces resistance to IL-1β-induced sickness behavior. Mice were subjected to either a 
24 h fast (Fasted), or continued to feed ad lib (Fed) prior to IL-1β or vehicle (Saline) at 0 h. (A) A juvenile 
was introduced 2 h post injection, and social interaction was measured as seconds (s) spent investigating  
juvenile for a duration of 5 minutes, means (±SEM); n=8. Bars without a common superscript are 
different (*p <0.05). (B) 2 h post injection, spontaneous locomotor activity was measured for 5 minutes. 
Results are expressed as total distance traveled in centimeters (cm), means (  SEM); n=4. Bars without 
a common superscript are different (*p <0.05).  
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Figure 2 (cont.)  Fasting induces resistance to IL-1β-induced sickness behavior. Mice were subjected to 
either a 24 h fast (Fasted), or continued to feed ad lib (Fed) prior to IL-1β or vehicle (Saline) at 0 h. (C) 
Mice were weighed 2 h post injection and compared to their weight at 0 h. Results are expressed as 
weight change from 0 h in grams (g), means (  SEM); n=4-5. Bars without a common superscript are 
different (*p<0.05). (D) Blood Glucose was measured 2 h post injection and compared to 0 h blood 
glucose measurement for each individual mouse. Results are expressed as change in blood glucose 
(mg/dl), means  (  SEM); n=4-5. Bars without a common superscript are different (p<0.05).   
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Figure 3.  Effect of challenging mice with IL-1β on brain region cytokine transcripts. Mice were subjected 
to either a 24 h fast (Fasted), or continued to feed ad lib (Fed) prior to IL-1β or vehicle (Saline) at 0 h. 2 h 
post injection,  brain regions were harvested (Hypothalamus-Hypoth, Hippocampus-Hippoc, Cortex-
Cortex). (A)  IL-1R2 gene transcripts were measured and compared to set control group within each 
separate region (Fed, Saline). Results are expressed as relative fold change in mRNA, means (+ SEM 
Upper); n=4. Bars without a common superscript are different (*p <0.05). (B) IL-1RA gene transcripts 
were measured and compared to set control group within each separate brain region (Fed, Saline). 
Results are expressed as relative fold change in mRNA, means (+ SEM Upper); n=4. Bars without a 
common superscript are different (*p <0.05).  
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Figure 3 (cont.).  Effect of challenging mice with IL-1β on brain region cytokine transcripts. Mice were 
subjected to either a 24 h fast (Fasted), or continued to feed ad lib (Fed) prior to IL-1β or vehicle (Saline) 
at 0 h. 2 h post injection,  brain regions were harvested (Hypothalamus-Hypoth, Hippocampus-Hippoc, 
Cortex-Cortex).(C) IL-1α gene transcripts were measured and compared to set control group within each 
separate brain region (Fed, Saline). Results are expressed as relative fold change in mRNA, means (+ 
SEM Upper); n=4. Bars without a common superscript are different (*p <0.05). (D) IL-1β gene transcripts 
were measured and compared to set control group within each separate brain region (Fed, Saline). 
Results are expressed as relative fold change in mRNA, means (+ SEM Upper); n=4. Bars without a 
common superscript are different (*p <0.05).    
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Figure 4.  Substantial up-regulation in liver and adipose IL-1R2 gene expression, and in liver IL-1RA gene 
expression and their correlations to percent weight loss. These graphs represent a collective description 
of data from numerous cohorts of mice that were either fast (Fasted) for 24 h, or continued to feed ad 
lib (Fed). Box plots are representative of the summated relative fold changes in mRNA transformed to 
log; the box outlines the lower 1st quartile and upper 3rd quartile, the vertical bars represent the 
largest/smallest non-outlier observation, the thick horizontal line represents the mean of the relative 
fold change values and the thin horizontal line is the median, and black circles represent outliers (A) 
Liver IL-1R2 gene transcription results are summarized and expressed as log (average relative fold 
change (∆mRNA)) for fed (n=29) and fasted groups (n=31) *p<0.001. (B) Percent weight lost per mouse 
was correlated to their dCT value for IL-1R2 in the adipose, significant correlation was observed p<0.001, 
n=30. 
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Figure 4 (cont.).  Substantial up-regulation in liver and adipose IL-1R2 gene expression, and in liver IL-
1RA gene expression and their correlations to percent weight loss. These graphs represent a collective 
description of data from numerous cohorts of mice that were either fast (Fasted) for 24 h, or continued 
to feed ad lib (Fed). Box plots are representative of the summated relative fold changes in mRNA 
transformed to log; the box outlines the lower 1st quartile and upper 3rd quartile, the vertical bars 
represent the largest/smallest non-outlier observation, the thick horizontal line represents the mean of 
the relative fold change values and the thin horizontal line is the median, and black circles represent 
outliers. (C) Adipose IL-1R2 gene transcription results are summarized and expressed as log (average 
relative fold change (∆mRNA)) for fed (n=29) and fasted groups (n=30) *p<0.001.(D) Percent weight lost 
per mouse was correlated to their dCT value for IL-1R2 in the adipose, significant correlation was 
observed p<0.001, n=30.  
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Figure 4 (cont.).  Substantial up-regulation in liver and adipose IL-1R2 gene expression, and in liver IL-
1RA gene expression and their correlations to percent weight loss. These graphs represent a collective 
description of data from numerous cohorts of mice that were either fast (Fasted) for 24 h, or continued 
to feed ad lib (Fed). Box plots are representative of the summated relative fold changes in mRNA 
transformed to log; the box outlines the lower 1st quartile and upper 3rd quartile, the vertical bars 
represent the largest/smallest non-outlier observation, the thick horizontal line represents the mean of 
the relative fold change values and the thin horizontal line is the median, and black circles represent 
outliers (E) Liver IL-1RA gene transcription results are summarized and expressed as log (average relative 
fold change (∆mRNA)) for fed (n=29) and fasted groups (n=31) *p<0.001.(F) Percent weight lost per 
mouse was correlated to their dCT value for IL-1RA in the liver, no significant correlation, n=31. 
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Figure 5. IL-1R2 and IL-1RA gene expression on isolated liver cells. Mice were subjected to either a 24 h 
fast (Fasted), or continued to feed ad lib (Fed), and cells were isolated. (A) RNA was extracted from 
CD11b+ and CD11b- cells isolated from liver, IL-1R2 results are expressed as relative fold change 
(∆mRNA) compared to control CD11b+ Fed group, means (+ SEM Upper, - SEM Lower); n=8. Bars 
without a common superscript are different (*p <0.05). (B) IL-1RA results are expressed as relative fold 
change (∆mRNA) compared to control CD11b+ Fed group, means (+ SEM Upper, - SEM Lower); n=8. Bars 
(C) RNA was extracted from hepatocytes isolated from liver and IL-1R2 gene expression was measured. 
Results are expressed as relative fold change (∆mRNA), means (+ SEM Upper, - SEM Lower); n=4. (D) IL-
1R2 gene expression was measured. Results are expressed as relative fold change (∆mRNA), means (+ 
SEM Upper, - SEM Lower); n=4. *p <0.05. (E) Liver was harvested from mice and RNA was either 
extracted immediately, within 1 hour (1 h), or extracted 6 hours after harvest (6 h). IL-1R2 and IL-1RA 
gene expression was measured. Results are expressed as relative fold change (∆mRNA), means (+ SEM 
Upper, - SEM Lower); n=4. *p <0.05. 
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Table 3
Effect of fasting on gene expression of IL-1R2 and IL-1RA in liver and adipose of knockout mouse models.
IL-1R2 IL-1RA
Genotype Fed Fasted Fed Fasted
IL-1R1 KO Liver 1.000 
(+0.33,-0.24)
8.306*
(+7.09,-3.82)
1.000
(+0.08,-0.07)
16.271*
(+2.06,-1.82)
Adipose 1.000
(+0.24,-0.19)
18.783*
(+37.2,-9.31)
1.000 
(+0.14,-0.12)
0.589
(+0.87,-0.19)
TLR-4 KO Liver 1.000 
(+0.30,-0.23)
7.605*
(+7.71,-3.83)
1.000 
(+0.58,-0.37)
16.420*
(+10.4,-6.37)
Adipose 1.000           
(+0.28,-0.24)
9.863*      
(+18.9,-6.48)
1.000                                  
(+0.43,-0.31)
0.759              
(+0.23,-0.17)
IL-4 KO Liver 1.000 
(+0.19,-0.16)
8.129*
(+10.9,-4.66)
1.000 
(+0.30,-0.23)
13.678*
(+5.04,-3.68)
Adipose 1.000 
(+0.19,-0.16)
22.768*
(+35.5,-13.8)
1.000 
(+0.10,-0.09)
0.545
(+0.24,-0.17)
Results are expressed as relative fold change in mRNA expression (∆mRNA), means (+SEM upper, -SEM 
lower); IL-1R1 KO n=4. TLR-4 KO n=7. IL-4 KO n=4. 
* p< 0.05, significant (One-way ANOVA)
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Figure 6.  Effect of fasting on plasma corticosterone levels in mice. Mice were subjected to either a 24 h 
fast (Fasted), or continued to feed ad lib (Fed) before blood was harvested. (A) Corticosterone was 
measured and compared to control group (Fed). Results are expressed as ng/mL corticosterone, means 
(±SEM); n=5-7. Significant main effect (*p <0.05). (B) Corticosterone levels in ng/mL were positively 
correlated to percent weight lost by mouse; n=5-7, p=0.005.  
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Figure 7.  Effect of inhibiting glucocorticoid receptor activity on IL-1R2 and IL-1RA gene transcripts in 
liver. After injecting GCR antagonist (Mifepristone), vehicle (PEG) or sham scruffing with no injection 
(None), mice were subjected to either a 24 h fast (Fasted), or continued to feed ad lib (Fed). (A) Liver IL-
1R2 gene transcripts were measured and compared to set control group (Fed None). Results are 
expressed as relative fold change in mRNA, means (+ SEM Upper, - SEM Lower); n=4-6. Bars without a 
common superscript are different (*p <0.05). (B) Liver IL-1RA gene transcripts were measured and 
compared to set control group (Fed None). Results are expressed as relative fold change in mRNA, 
means (+ SEM Upper, - SEM Lower); n=4-6. Bars without a common superscript are different (*p <0.05). 
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Figure 8.  Effect of fasting and palmitic acid injection on NEFA levels in mice. (A) Mice were subjected to 
either a 24 h fast (Fasted), or continued to feed ad lib (Fed) before blood was harvested. Plasma NEFAs 
were measured and results are expressed as mmol/L, fed vs. fasted, means (±SEM); n=3-4. Significant 
main effect (*p<0.001). (B) Mice were injected with palmitic acid or vehicle control and 2 h after 
injection blood was harvested. Plasma NEFAs were measured and results are expressed as mmol/L, 
Vehicle vs. Palmitic, means (±SEM); n=6. Significant main effect (*p <0.05). 
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Figure 9.  Liver IL-1R2 gene transcription levels after palmitic acid injection. Mice were injected with 
palmitic acid or vehicle control and 2 h after injection liver was harvested and RNA was extracted. (A) 
Results are expressed as relative fold change in mRNA, means (+ SEM Upper, -SEM Lower); n=6. 
Significant main effect (*p <0.05). (B) TLR-4 KO liver IL-1R2 gene transcripts were compared to control 
group (WT, Vehicle). Results are expressed as relative fold change in mRNA, means (+ SEM Upper, -SEM 
Lower); n=8. Bars without a common superscript are different (*p <0.001). 
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CHAPTER 6 
DISCUSSION 
 
This project was able to successfully identify immune regulators impacted by a 24 h fast.  As 
evidenced in Table 1, fasting differentially regulated transcripts of cytokines in brain regions compared 
to liver and adipose. This decoupling of immune phenotype of the brain indicates that tissues involved in 
energy supply, during nutrient deprivation, may have the potential to prevent, treat or exacerbate 
disease. CD11b is a complement receptor and  has mainly been shown to have a central role in host 
defense in which it enhances  migration of leukocytes (ex. macrophages and microglia) from peripheral 
blood to sites of inflammation  (Kataru et al., 2009). Here we show that CD11b gene transcription  is 
significantly down-regulated in all brain regions, whereas CD11b is up-regulated in adipose and liver in 
response to fasting. These perturbations may indicate a brain preparatory shift to anti-inflammation.  
Different from CD11b, TNF-α gene transcription is consistently down-regulated throughout all tissues 
investigated. TNF-α  is produced by macrophages and  is known best for its role in promoting 
inflammatory responses, inducing fever and anorexia (MacEwan, 2002). It is logical for fasting to down-
regulate  genes responsible for inducing anorexia in times of nutrient deprivation.   
 
Many changes were seen in transcription of the IL-1 family due to fasting. IL-1α was down-
regulated in all brain regions without significantly affecting the peripheral tissues, and IL-1β was 
significantly decreased only in the hypothalamus and adipose.  These markers indicate a general 
dampening of inflammation in these tissues. The IL-1 family is an important part of the innate immune 
system and its balance is extremely essential to mediate inflammation and tissue damage. Because 
uncontrolled IL-1 is implicated in the pathogenesis of a variety of inflammatory conditions and diseases 
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(Dinarello, Simon, & van der Meer, 2012), mechanisms tightly controlling its potentially potent activity 
at multiple levels is extremely important. For this reason, one way IL-1 is counterbalanced is by two 
distinct endogeneous inhibitors, IL-1RA and IL-1R2. IL-1RA transcription was shown to be up-regulated in 
the hippocampus and liver, but down-regulated in the adipose. IL-1R2 was not up-regulated in any of 
the brain tissues, but was instead substantially significantly up-regulated in both adipose and liver (Table 
1). This IL-1R2 up-regulation was consistent throughout numerous experiments, but produced extremely 
variable fold changes which we found to be related to its correlation to percent body weight loss during 
the 24 h fast (Fig. 4). IL-1RA is a competitive inhibitor that can antagonize the pro-inflammatory effects 
via binding with near equal avidity as IL-1 to the signaling IL-1 receptor (IL-1R1) without causing 
activation of the cells (Symons, Young, & Duff, 1995). Although less is understood about IL-1R2, it has 
primarily been demonstrated to function as an important negative regulator, acting like a decoy 
receptor binding IL-1 both on the plasma membrane and as a soluble receptor in fluid phase, preventing 
the interaction of IL-1 with IL-1R1 (Arend, 2002; Bossu et al., 1995; Rauschmayr, Groves, & Kupper, 
1997; Re et al., 1996). As Table 2 shows, these mRNA transcription up-regulations were confirmed to 
translate into an increase in liver protein of both IL-1RA and IL-1R2. Interestingly, these increases in the 
IL-1 inhibitor proteins were not seen in serum of fasted mice.  These results suggest these normally 
secreted proteins are remaining intracellular or remaining in the interstitial fluid within the liver. More 
recently, studies have elucidated a new level of control for IL-1 in which IL-1R2 has been shown to 
interact with precursor form IL-1α intracellularly (Chang, Su, & Lee, 2009; Kawaguchi et al., 2006), and 
this interaction was just confirmed in Cell where it was found that IL-1R2 is bound to pro-IL-1α 
intracellularly during times of stress-induction, preventing IL-1 from further processing into its mature 
form. Binding of proIL-1α and IL-1R2 was able to control and prevent necrosis-induced sterile 
inflammation (Zheng, Humphry, Maguire, Bennett, & Clarke, 2013). 
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Sickness Behaviors are defined as adaptive, physiological and behavioral changes that occur in 
response to infection and inflammation (Hart, 1988). Furthermore, a dramatic reduction in food intake is 
commonly associated with illness during localized and systemic diseases (Hart, 1988; Konsman & 
Dantzer, 2001), but this disease-associated anorexia is dependent on the feeding status, as it has been 
shown that the anorexic effect is attenuated when restricting food intake prior to IL-1β or turpentine-
induced sickness (Kent, Rodriguez, Kelley, & Dantzer, 1994; Larson, Romanoff, Dunn, & Glowa, 2002; 
Lennie, 1998; Mrosovsky, Molony, Conn, & Kluger, 1989). Acute starvation has also been shown to 
attenuate the fever response to LPS in rats (Inoue et al., 2008; Shido, Nagasaka, & Watanabe, 1989).  
Here we showed (Fig.2) that fasting prior to peripheral IL-1B challenge was able to attenuate weight loss 
and IL-1β- induced hypoglycemia at 2 h post injection. Fasted animals were also resistant to reduction in 
locomotor activity and social behavior. Proinflammatory cytokines, such as those included in the IL-1 
family, can act at the periphery to induce its own synthesis and the synthesis of other cytokines allowing 
it to potentiate or oppose its effects, and these signals can induce the expression of transcripts of 
inflammatory cytokines in the brain in response to peripheral stimuli (Sims and smith, 2010). Here, we 
uncover a link between dietary restrictions effect being that of up-regulation of IL-1 family antagonistic 
mediators within the liver, which then blunts the centrally-mediated effects of induced peripheral 
challenge. The importance of the liver in transmitting cytokine signals from the periphery to the brain 
after i.p.- injected inflammatory stimuli has been shown previously by those investigating the effects of 
subdiaphragmatic vagotomy. The vagus nerve, by which the liver is innervated, has an important role in 
transmitting peripheral cytokine signals to the brain as evidenced by rodents injected i.p. with IL-1β, in 
which vagotomy was able to substantially attenuate any increase in IL-1β mRNA in the brain, and block 
behavioral effects of IL-1β injected i.p., whereas IL-1β  mRNA increase in liver was not affected and the 
behavioral effects were not different if injected i.v. or i.c.v. (Bluthe, Michaud, Kelley, & Dantzer, 1996a; 
Bluthe, Michaud, Kelley, & Dantzer, 1996b; Hansen, Taishi, Chen, & Krueger, 1998). Although we did not 
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see an attenuation of IL-1α or IL-1β gene transcription 2 h after IL-1β peripheral challenge in any brain 
regions (Fig. 3), we did observe a significant increase in IL-1R2 message in fasted mice challenged with 
IL-1β in the cortex, and we also saw a significant decrease in fasted mice IL-1RA in the hypothalamus 2 h 
after IL-1B challenge. Because of the nature of IL-1RA inhibiting IL-1, sources have suggested that 
increased IL-1RA can actually be a marker of severity of inflammation  rather than expression of anti-
inflammation (Pihlajamaki et al., 2012).  This implies for our results that the decrease in IL-1RA in the 
hypothalamus is indicative of a lesser inflammatory process occurring in the fasted mice compared to 
fed. This data suggests that the liver, which we have now found to be basally skewed anti-inflammatory 
via acute food deprivation, plays a major role in communicating inflammatory signals to the brain after 
an i.p. immune challenge. 
 
When trying to elucidate a mechanism as to how fasting up-regulates these anti-inflammatory 
cytokines, we tried to look at which cells within the liver were expressing the messages. Fig. 5 shows 
that we were unable to find significant up-regulation of IL-1R2 or IL-1RA in either CD11b+ or CD11b- cell 
fractions, however, when we look at cellular fractions of hepatocytes, we were able to uncover IL-1RA 
up-regulation which is consistent with current findings (Gabay, Gigley, Sipe, Arend, & Fantuzzi, 2001). It 
was then discovered  that because processing  necessary to isolate the cells of the liver took up to 6 
hours for PCR(without fixation), IL-1R2 was rapidly degraded due to IL-1R2 transcripts short half-life of 
only 110 min. (Zeisel et al., 2011), and this degradation is the probable cause of our inability to see IL-
1R2 up-regulation in any cellular fraction.  This was confirmed by setting out a piece of liver tissue for 6 
h (the time it takes to isolate cells) and comparing it to a piece of liver that was immediately extracted, 
in which our results show after 6 h the IL-1R2 message is practically undetectable. 
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IL-1R2 expression has been shown to be induced by numerous agents in vitro including 
dexamethasone, prostaglandins, glucocorticoids, IL-4, IL-13, IL-27 and aspirin (Peters, Joesting, & 
Freund, 2012). Using knockout mouse models (Table 3), it was determined that IL-1R2 and IL-1RA gene 
transcription in the liver and adipose due to fasting is independent of IL-1 (as demonstrated by IL-1R1 
KO), TLR-4, or IL-4 signaling. Food deprivation is also known to cause many hormonal effects that are 
implicated in influencing the immune response. These include; inhibited insulin secretion, decreased 
leptin, increased glucagon, epinephrine and glucocordicoids, and the main metabolic purpose of these 
changes are to reduce glucose use while stimulating lipolysis and ketogenesis (Finn & Dice, 2006; 
Schwartz & Seeley, 1997). We confirmed the glucocordicoid, corticosterone, to be elevated in our model 
in the serum of fasted mice, demonstrated in Fig. 6, and, as with IL-1R2 up-regulation, this increase in 
corticosterone was correlated to percent body weight loss during the 24 h fast. Although corticosterone 
seemed like the logical candidate signaling to the cells to increase IL-1R2, Fig. 7 proves otherwise, 
showing through inhibition of glucocorticoid receptors via mifepristone injection that IL-1R2 and IL-1RA 
up-regulation in the liver is independent of corticosterone signaling. This mimics results showing 
protection against renal ischemic reperfusion injury induced by preoperative fasting up to 3 days by 
mice is mediated by corticosterone-independent mechanisms as glucocorticoid receptor blockade does 
not interfere with the protective effects of fasting (Van Ginhoven, Van Den Berg, Dik, Ijzermans, & De 
Bruin, 2010).  
 
An additional known effect of fasting is increased plasma Free Fatty Acids, where rats fasted for 
24 h had a 75% increase in serum NEFA concentration and 120% increase after 48 h (Pires, Curi, & 
Otton, 2007). We confirmed that our fasting models have increased plasma NEFA levels after a 24 h fast 
(Fig. 8). We were able to mimic plasma fasting NEFA levels by injecting palmitic acid into the periphery. 
Using this technique, palmitic acid is able to stimulate the increase in IL-1R2 message in liver 2 h after 
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being injected (Fig. 9), and this effect of FFAs on IL-1R2 up-regulation is independent of TLR-4 signaling 
(as shown by TLR-4 KO models). Ruling out TLR-4 signaling which is the generally accepted signaling 
receptor responsible for detecting saturated fatty acids and provoking an inflammatory response 
(Milanski et al., 2009). Instead, the probable candidate recognizing FFAs, causing induction of these anti-
inflammatory markers is free fatty acid receptor 1 (FFA1), which recognizes medium and long chain fatty 
acids.  It has been shown that NEFAs can trigger apoptosis in different cells lines (Cury-Boaventura, 
Pompeia, & Curi, 2005; Finstad et al., 1998). Significant fasting-induced apoptosis has also been shown 
to occur in rat liver after 2 days of fasting. This model resulted in an approximate 19% loss in body 
weight (Tessitore, Tomasi, & Greco, 1999), and as stated previously, IL-1R2 has just been implicated as 
the protein responsible for preventing  inflammation during apoptotic stress (Zheng et al., 2013). FFA1 is 
a GPR that: 1) recognizes fatty acids relevant to dietary ingestion; 2) is expressed on cells and tissues key 
to neuroimmunity namely macrophages and brain; 3) and likely signals through kinases critical to 
macrophage function and activation. These features of FFA1 implicate it as a regulator of 
immunobehaviors and warrants significant further study. 
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CHAPTER 7 
CONCLUSIONS 
 
In conclusion, this project shows fasting increases IL-1R2 in the liver and adipose, and IL-1RA in 
the liver, and these increases represent a novel way in which fasting is able to attenuate sickness 
behaviors resulting from a peripheral IL-1β challenge.  We have been able to rule out numerous 
mechanisms that are known to increase transcription of IL-1R2 including IL-1, TLR-4, IL-4 and 
glucocordicoid signaling. Instead, this research project introduces a new mechanism by which IL-1R2 is 
up-regulated via FFAs. Using these results and new literature elucidating the role of IL-1R2, our current 
hypothesis is that IL-1R2 is up-regulated in peripheral tissues resulting from stress-induced (24 h fast) 
increase in epinephrine and FFA. Furthermore, these FFA are signaling “danger” to the cells via FFAR1, 
which is the cause of intracellular up-regulation of IL-1R2/IL-1RA in the form of a preparatory response 
for possible apoptosis and prevention of IL-1α-induced necrosis upon apoptosis. We anticipate that once 
a challenge has been sensed (i.e. peripheral IL-1β injection), the increased reservoir of anti-inflammatory 
contents within these cells is released, providing an initial blunting of IL-1 signaling and centrally-
mediated sickness responses. More investigation is necessary to confirm this hypothesis. We have 
proposed experiments including looking at protein in the blood after fasted mice have been challenged 
with IL-1β, using cell culture and flow cytometry and/or immunostaining analysis to determine which 
form of IL-1R2 is up-regulated in response to FFA (intracellular, soluble, membrane bound), blocking 
epinephrine and/or FFA during a fast, and we also propose to determine just how much circulating IL-
1R2 at any given time is bound to IL-1. The implications of this project are important because this may 
elucidate the mechanism behind the plethora of health benefits known to be induced by fasting, and 
also because of the numerous ailments known to be driven by inflammatory IL-1, in which new 
ameliorations that inhibit IL-1 bioaction may positively impact. 
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